(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:1309761 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRAIP mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE decreases expression ISO RGD:1309761 6480464 Topotecan results in decreased expression of TRAIP mRNA CTD PMID:25729387 1-naphthyl isothiocyanate increases expression ISO RGD:1309761 6480464 1-Naphthylisothiocyanate results in increased expression of TRAIP mRNA CTD PMID:30723492 17beta-estradiol decreases expression ISO RGD:1601884 6480464 Estradiol results in decreased expression of TRAIP mRNA CTD PMID:23373633 1H-pyrazole multiple interactions ISO RGD:1309761 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of TRAIP mRNA CTD PMID:16610055 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions EXP 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1601884 6480464 Tetrachlorodibenzodioxin results in decreased expression of TRAIP mRNA CTD PMID:19684285 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of TRAIP mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of TRAIP mRNA CTD PMID:12167310 , PMID:19465110 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1601884 6480464 Tetrachlorodibenzodioxin results in increased expression of TRAIP mRNA CTD PMID:19684285 6-propyl-2-thiouracil increases expression ISO RGD:1309761 6480464 Propylthiouracil results in increased expression of TRAIP mRNA CTD PMID:24780913 , PMID:25825206 benzo[a]pyrene decreases expression ISO RGD:1601884 6480464 Benzo(a)pyrene results in decreased expression of TRAIP mRNA CTD PMID:20064835 benzo[a]pyrene increases expression ISO RGD:1601884 6480464 Benzo(a)pyrene results in increased expression of TRAIP mRNA CTD PMID:17879257 bisphenol A decreases expression ISO RGD:1309761 6480464 bisphenol A results in decreased expression of TRAIP mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1601884 6480464 bisphenol A results in decreased expression of TRAIP mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:1309761 6480464 bisphenol A results in increased methylation of TRAIP gene CTD PMID:28505145 bisphenol A decreases methylation EXP 6480464 bisphenol A results in decreased methylation of TRAIP promoter CTD PMID:27312807 calcitriol decreases expression ISO RGD:1601884 6480464 Calcitriol results in decreased expression of TRAIP mRNA CTD PMID:21592394 calcitriol multiple interactions ISO RGD:1601884 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRAIP mRNA CTD PMID:21592394 carbon nanotube increases expression EXP 6480464 Nanotubes, Carbon analog results in increased expression of TRAIP mRNA, Nanotubes, Carbon results in increased expression of TRAIP mRNA CTD PMID:25554681 choline multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TRAIP mRNA CTD PMID:20938992 cisplatin increases expression ISO RGD:1601884 6480464 Cisplatin results in increased expression of TRAIP mRNA CTD PMID:27594783 copper(II) sulfate decreases expression ISO RGD:1601884 6480464 Copper Sulfate results in decreased expression of TRAIP mRNA CTD PMID:19549813 dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of TRAIP mRNA CTD PMID:21266533 dichloroacetic acid increases expression EXP 6480464 Dichloroacetic Acid results in increased expression of TRAIP mRNA CTD PMID:28962523 ethanol multiple interactions ISO RGD:1309761 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of TRAIP mRNA CTD PMID:16610055 ethyl methanesulfonate increases expression ISO RGD:1601884 6480464 Ethyl Methanesulfonate results in increased expression of TRAIP mRNA CTD PMID:23649840 folic acid affects expression ISO RGD:1601884 6480464 Folic Acid affects the expression of TRAIP mRNA CTD PMID:16361273 folic acid multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TRAIP mRNA CTD PMID:20938992 furan increases expression ISO RGD:1309761 6480464 furan results in increased expression of TRAIP mRNA CTD PMID:25539665 geraniol decreases expression ISO RGD:1601884 6480464 geraniol results in decreased expression of TRAIP mRNA CTD PMID:27683099 ketamine increases expression ISO RGD:1309761 6480464 Ketamine results in increased expression of TRAIP mRNA CTD PMID:20080153 L-methionine multiple interactions EXP 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TRAIP mRNA CTD PMID:20938992 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of TRAIP mRNA CTD PMID:18502557 methyl methanesulfonate increases expression ISO RGD:1601884 6480464 Methyl Methanesulfonate results in increased expression of TRAIP mRNA CTD PMID:23649840 oxaliplatin decreases expression ISO RGD:1309761 6480464 oxaliplatin results in decreased expression of TRAIP mRNA CTD PMID:25729387 oxaliplatin multiple interactions ISO RGD:1309761 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRAIP mRNA CTD PMID:25729387 p-menthan-3-ol decreases expression ISO RGD:1601884 6480464 Menthol results in decreased expression of TRAIP mRNA CTD PMID:26760959 paracetamol increases expression ISO RGD:1601884 6480464 Acetaminophen results in increased expression of TRAIP mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:1601884 6480464 Acetaminophen results in decreased expression of TRAIP mRNA CTD PMID:26690555 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1601884 6480464 perfluorooctane sulfonic acid results in increased expression of TRAIP mRNA CTD PMID:27153767 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of TRAIP mRNA CTD PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of TRAIP mRNA CTD PMID:22698814 rotenone decreases expression ISO RGD:1601884 6480464 Rotenone results in decreased expression of TRAIP mRNA CTD PMID:29955902 sodium arsenite increases expression ISO RGD:1601884 6480464 sodium arsenite results in increased expression of TRAIP mRNA CTD PMID:29301061 sodium dichromate affects expression ISO RGD:1309761 6480464 sodium bichromate affects the expression of TRAIP mRNA CTD PMID:22110744 Soman decreases expression ISO RGD:1309761 6480464 Soman results in decreased expression of TRAIP mRNA CTD PMID:19281266 testosterone multiple interactions ISO RGD:1601884 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of TRAIP mRNA CTD PMID:21592394 testosterone decreases expression ISO RGD:1601884 6480464 Testosterone results in decreased expression of TRAIP mRNA CTD PMID:21592394 tetrachloromethane multiple interactions ISO RGD:1309761 6480464 [Ethanol co-treated with pyrazole co-treated with Carbon Tetrachloride] results in increased expression of TRAIP mRNA CTD PMID:16610055 tetrachloromethane increases expression ISO RGD:1309761 6480464 Carbon Tetrachloride results in increased expression of TRAIP mRNA CTD PMID:30723492 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of TRAIP mRNA CTD PMID:27760801 topotecan decreases expression ISO RGD:1309761 6480464 Topotecan results in decreased expression of TRAIP mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:1309761 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of TRAIP mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of TRAIP mRNA CTD PMID:25549359 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of TRAIP mRNA CTD PMID:19042947 tungsten increases expression EXP 6480464 Tungsten results in increased expression of TRAIP mRNA CTD PMID:30912803 tungsten(4+) increases expression EXP 6480464 Tungsten results in increased expression of TRAIP mRNA CTD PMID:30912803 zoledronic acid increases expression ISO RGD:1601884 6480464 zoledronic acid results in increased expression of TRAIP mRNA CTD PMID:20977926
Biological Process negative regulation of interferon-beta production IDA 2290270 (MGI:MGI:5619447, PMID:22945920) CACAO MGI:MGI:5619447 , PMID:22945920 negative regulation of NF-kappaB transcription factor activity IDA 2290270 (MGI:MGI:86532, PMID:9109628) MGI MGI:MGI:86532 , PMID:9109628 negative regulation of tumor necrosis factor-mediated signaling pathway ISO UniProtKB:Q9BWF2 2290270 MGI GO_REF:0000096, MGI:MGI:4834177 protein ubiquitination IDA 2290270 (MGI:MGI:5553244, PMID:17544371) FlyBase MGI:MGI:5553244 , PMID:17544371 signal transduction IDA 2290270 (MGI:MGI:86904, PMID:9104814) MGI MGI:MGI:86904 , PMID:9104814 signal transduction IPI UniProtKB:P39428 2290270 (MGI:MGI:86904, PMID:9104814) MGI MGI:MGI:86904 , PMID:9104814 Cellular Component cytoplasm IEA UniProtKB-KW:KW-0963 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 nucleus IEA UniProtKB-KW:KW-0539 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 Molecular Function metal ion binding IEA UniProtKB-KW:KW-0479 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 protein binding IPI UniProtKB:P39428 2290270 (MGI:MGI:86904, PMID:9104814) MGI MGI:MGI:86904 , PMID:9104814 transferase activity IEA UniProtKB-KW:KW-0808 2290270 UniProtKB GO_REF:0000004, MGI:MGI:1354194 ubiquitin protein ligase activity IDA 2290270 (MGI:MGI:5553244, PMID:17544371) MGI MGI:MGI:5553244 , PMID:17544371 ubiquitin-protein transferase activity IDA 2290270 (MGI:MGI:5553244, PMID:17544371) FlyBase MGI:MGI:5553244 , PMID:17544371
Gene-Chemical Interaction Annotations
